Search

everythinglearnresearchcommunity

for

Search:↓

Taking hormonal contraceptives can cause skin changes, including hair loss, due to the effects of synthetic sex hormones.

Isotretinoin therapy for acne can cause many reversible side effects, mainly mild skin conditions, and patient understanding of these effects can improve treatment adherence.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Foam corticosteroid covers as well as traditional forms.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

New microneedle method improves hair regrowth treatment delivery.

A young woman developed a vision-threatening eye condition after using minoxidil for hair loss, which improved when she stopped the medication.

Microneedles with extracellular vesicles show promise for treating various conditions with targeted delivery.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Acitretin is effective for severe skin conditions but has significant side effects and requires careful monitoring.

Understanding and managing side effects of hedgehog pathway inhibitors can improve treatment for advanced basal cell carcinoma.

Testosterone replacement can help women with low libido and mood, but they need to have enough estrogen first to avoid side effects.

Microneedle technology has advanced for painless drug delivery and sensitive detection but faces a gap between experimental use and clinical needs.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

PCOS is a condition causing irregular periods, excess male hormones, and infertility, often managed by targeting insulin resistance and specific symptoms.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

Antiandrogens help manage PCOS symptoms but need careful monitoring.

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

Testosterone therapy for postmenopausal women appears safe and may protect against heart disease, but requires constant monitoring and more research for long-term effects.

Transgender and gender-diverse adults on hormone therapy often face drug-hormone interactions, especially with multiple psychotropic medications.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Some common medications may harm male fertility by affecting hormones, sperm production, and sexual function.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

The combination treatment showed a higher response rate but no significant survival benefits.